May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Fluorescein Angiography of Pediatric Iris Tumors and Pseudotumors
Author Affiliations & Notes
  • C. J. Danzig
    Ophthalmology, Charles R. Drew University, Los Angeles, California
  • A. Mashayehki
    Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania
  • C. L. Shields
    Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania
  • J. A. Shields
    Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships C.J. Danzig, None; A. Mashayehki, None; C.L. Shields, None; J.A. Shields, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3606. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. J. Danzig, A. Mashayehki, C. L. Shields, J. A. Shields; Fluorescein Angiography of Pediatric Iris Tumors and Pseudotumors. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3606.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To demonstrate the usefulness of intravenous fluorescein angiography (IVFA) in differentiating pediatric iris tumors and pseudotumors.

Methods:: Non-comparative case series of 6 patients.

Results:: All lesions except iris pigment epithelial cyst demonstrated early and late hyperfluorescence. Iris stromal cyst showed mild, late pooling of fluorescein. Medulloepithelioma revealed late leakage around the lesion and uninvolved pupillary margin. Juvenile xanthogranuloma displayed diffuse, late hyperfluorescence of the lesion and entire uninvolved iris. Ectopic lacrimal gland choristoma and malignant melanoma had late leakage.

Conclusions:: IVFA may be useful in evaluating pediatric patients with iris tumors and pseudotumors.

Keywords: tumors • iris 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×